PolyScience’s recirculating chillers and refrigerated circulators control temperature with stabilities as precise as ±0.005 °C for analytical instrumentation.
PolyScience’s recirculating chillers and refrigerated circulators control temperature with stabilities as precise as ±0.005 °C for analytical instrumentation. The products are designed for maintaining atomic absorption furnaces, gas chromatographs, mass spectrometers, inductively coupled plasma, and other analytical equipment at optimal working temperatures.
Recommended for either broad temperature ranges or precise temperature control, the circulators maintain temperatures over a range as wide as -40° to +200 °C with ±0.005 °C stability, 200 to 1400 watts of cooling at 20 °C, reservoir sizes from 7-75 L, and offered with six different temperature controllers, including two programmable models.
The chillers are designed for higher cooling capacities, available in benchtop and portable models, delivering 460 to 5200 watts of heat removal at 20 °C, with working temperatures as low as -20 °C up to +70 °C and stabilities as precise as ±0.1 °C.
PolyScience
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.